Showing 881-890 of 3597 results for "".
Revenue Cycle Management: What Physicians and Administrators Need to Know
https://practicaldermatology.com/topics/practice-management/revenue-cycle-management-what-physicians-and-administrators-need-to-know/23536/The latest generation of RCM software can benefit practices in multiple ways.Why Has the Market Gone Up When Economic News Looks Grim?
https://practicaldermatology.com/topics/practice-management/why-has-the-market-gone-up-when-economic-news-looks-grim/23314/A look at seven factors affecting the market.Why Telehealth is Needed and Why It’s Here to Stay
https://practicaldermatology.com/topics/practice-management/why-telehealth-is-needed-and-why-its-here-to-stay/23298/Tips for integrating teledermatology for now and the future.The Road Map to Success: When Does it Make Sense to Have a Dermatology PA?
https://practicaldermatology.com/topics/practice-management/the-road-map-to-success-when-does-it-make-sense-to-have-a-dermatology-pa/23235/Adding a new provider can increase access and boost the bottom line. But how do you choose?10 Things Dermatologists Need to Know About Treating Vitiligo Today
https://practicaldermatology.com/topics/pigmentary-disorders/10-things-dermatologists-need-to-know-about-treating-vitiligo-today/22988/New and emerging treatment approaches offer hope for this challenging condition.FAST ASK: Simplifying Challenging Conversations
https://practicaldermatology.com/topics/practice-management/fast-ask-simplifying-challenging-conversations/22982/SCALE Notes
https://practicaldermatology.com/issues/supplements/scale-notes/22088/News and views from Music City SCALEMicromanagement: Microparticles Enhance Outcomes of Energy-based Acne Care
https://practicaldermatology.com/topics/general-topics/micromanagement-microparticles-enhance-outcomes-of-energy-based-acne-care/20384/With recent FDA-clearance, microparticles are available to support Nd:YAG based treatment of inflammatory acne.Neurotoxins on the Horizon: Bonti and Beyond
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/neurotoxins-on-the-horizon-bonti-and-beyond/20321/Allergan's acquisition of Bonti highlights the burgeoning potential of the injectable neurotoxin market.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20409/